Maureen Sideris
Maureen Sideris, a cancer survivor, gained attention after sharing her remarkable experience with immunotherapy as a treatment for gastroesophageal junction cancer. Diagnosed in 2022, she participated in a groundbreaking trial at Memorial Sloan Kettering, where she achieved complete remission without the need for traditional treatments like surgery, chemotherapy, or radiation, leading her to describe her outcome as akin to winning the lottery.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Spain:
Maureen Sideris is a 71-year-old patient who has experienced complete remission of her gastroesophageal cancer.
9
United States:
Maureen Sideris, who was diagnosed with gastroesophageal junction cancer in 2022, subsequently became a participant in the trial.
8